Will cost keep new Alzheimer's drug from patients?
Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.
Source: politico.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Vicky Leamy. Real-time updates on events, politics, business and more.